Asiantuntijamme ovat kirjoittaneet, osallistuneet ja antaneet näkemystä satoihin julkaisuihin.
Hallinen T, Kivelä S, Soini E, et al. Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland. ClinicoEconomics and Outcomes Research 2023;15:1–13.
Petäjä U-K, Terkamo-Moisio A, Karki S, Häggman-Laitila A. The Prevalence of High-Risk Behavior Among Adolescents in Aftercare Services and Transitioning from Out-of-home Care: A Systematic Review. Adolesc Res Rev 2022.
Soini E, Lundström T, Taiha M, Mankinen P, Linden K. Epilepsy awareness and treatment satisfaction in Finland – An electronic survey for patients and close relation individuals. Dosis 2022; 38(3): 290–325.
Puolitaival A, Savola M, Tuomainen P, Asseburg C, Lundström T, Soini E. Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland. Adv Ther 2022.
Mälkönen T, Nuutinen P, Hallinen T, Soini E, et al. Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis. Acta Derm Venereol 2022; 102: adv00631.
Tew M, Willis M, Asseburg C, et al. Exploring structural uncertainty and impact of health state utility values on lifetime outcomes in diabetes economic simulation models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge. Med Decis Making 2021.
Terkamo-Moisio A, Karki S, Kangasniemi M, Lammintakanen J. Towards remote leadership in health care: Lessons learned from an integrative review. J Adv Nurs 2022;78:595–608.
Hallinen T, Soini E, Asseburg C, et al. Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation. Clinocoecon Outcomes Res 2021;13:745–755.
Kangasniemi M, Karki S, Voutilainen A, Saarnio R, Viinamäki L, Häggman-Laitila A. The value that social workers’ competencies add to health care: An integrative review. Health Soc Care Community 2022;30(2):403-414.
Sipponen T, af Björkesten CG, Hallinen T, Ilus T, Soini E, et al. A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland. Scand J Gastroenterol 2021.
Karki S, et al. The effects of interventions to prevent substance use among adolescents: A systematic review. Journal of Child & Adolescent Substance Abuse 2012; 21(5), 383–413.
Karki S, et al. Self-reported emotional and behavioral problems in Nepalese adolescents from urban and rural areas. Nurs Health Sci 2015;17(1):90-96.
Karki S, Länsimies H, Laukkanen E, Pirskanen M, Pietilä A-M. Substance use by adolescents in the Western Developmental Region of Nepal. J Subst Use 2016;21:1, 98-106.
Halkoaho A, Pietilä A-M, Ebbesen M, Karki S, Kangasniemi M. Cultural aspects related to informed consent in health research: A systematic review. Nurs Ethics 2016;23(6):698-712.
Kangasniemi M, Hipp K, Häggman-Laitila A, Kallio H, Karki S, et al. Optimoitu sote-ammattilaisten koulutus- ja osaamisuudistus. Valtioneuvoston selvitys- ja tutkimustoiminnan julkaisusarja 39/2018.
Häggman-Laitila A, Salokekkilä P, Karki S. Young People’s Preparedness for Adult Life and Coping After Foster Care: A Systematic Review of Perceptions and Experiences in the Transition Period. Child & Youth Care Forum 2019; 48(12):1-29.
Karki S. Substance use and psychosocial problems among Nepalese adolescents. Doctoral dissertation. Publications of the University of Eastern Finland. Dissertations in Health Sciences, 406. Kuopio: University of Eastern Finland, 2017.
Ronkainen V-P, Ronkainen JJ, Hänninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O, Tavi P. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007; 21(8): 1821-30.
Korhonen T, Hänninen SL, Tavi P. Model of excitation-contraction coupling of rat neonatal ventricular myocytes. Biophys J 2009; 96(3):1189-209.
Aydin J, Andersson DC, Hänninen SL, Wredenberg A, Tavi P, Park CB, Larsson N-G, Bruton JD, Westerblad H. Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy. Hum Mol Genet 2009; 18(2): 278-88.
Tavi P, Korhonen T, Hänninen SL, Bruton JD, Lööf S, Simon A, Westerblad H. Myogenic skeletal muscle satellite cells communicate by tunnelling nanotubes. J Cell Physiol 2010; 223(2): 376-83.
Hänninen SL, Ronkainen JJ, Leskinen H, Tavi. Mitochondrial uncoupling downregulates calsequestrin expression and reduces SR Ca2+ stores in cardiomyocytes. Cardiovasc Res 2010; 88(1):75-82.
Ronkainen JJ, Hänninen SL, Korhonen T, Koivumäki JT, Skoumal R, Rautio S, Ronkainen Veli-Pekka, Tavi P. Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation. J Physiol 2011; 598(Pt 11): 2669-86.
Karppinen S, Rapila R, Mäkikallio K, Hänninen SL, Rysä J, Vuolteenaho O, Tavi P. Endothelin-1 signalling controls early embryonic heart rate in vitro and in vivo. Acta Physiol (Oxf) 2014; 210(2): 369-80.
Karppinen S, Rapila R, Naumenko N, Tuomainen T, Koivumäki JT, Hänninen SL, Korhonen T, Tavi P. Ca2+-activated K+ current is essential for maintaining excitability and gene transcription in early embryonic cardiomyocytes. Acta Physiol 2015; 215: 7-9.
Karppinen S, Hänninen SL, Rapila R, Tavi P. Sarcoplasmic reticulum Ca2+ -induced Ca2+ release regulates class IIa HDAC localization in mouse embryonic cardiomyocytes. Physiol Rep. 2018; 6(2):e13522.
Häggman-Laitila A, Salokekkilä P, Karki S. Integrative review of the evaluation of additional support programs for care leavers making the transition to adulthood. J Pediatr Nurs 2020;54:63-77.
Af Björkesten CG, Ilus T, Hallinen T, Soini E, et al. Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort. Eur J Gastroenterol Hepatol 2020 (online ahead of print).
af Björkesten CG, Ilus T, Hallinen T, Soini E, et al. Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s disease. Digital Oral Poster (DOP) 26. Journal of Crohn's and Colitis 2020;14 (Issue Supplement 1):S066.
af Björkesten CG, Ilus T, Hallinen T, Soini E, et al. Objectively assessed disease activity during ustekinumab treatment in a nationwide real-life Crohn’s disease cohort. Journal of Crohn's and Colitis 2020;14 (Issue Supplement 1):S434–S435.